SS-31

Clinical Trials

Elamipretide (MTP-131)

Aliases
Elamipretide, MTP-131, Bendavia
Administration
Subcutaneous injection, IV infusion (clinical)

Documented benefits

Tier 1 · Peer-reviewed / regulatory

Longevity & Anti-Aging

SS-31's defining research application — directly targeting mitochondrial dysfunction, a hallmark of biological aging.

Anti-aging

Targets the cardiolipin structure in aging mitochondria, addressing a mechanism distinct from most anti-aging peptides.

ATP restoration

Stabilizes cardiolipin, helping mitochondria regain efficient ATP production.

Cardioprotection

Received FDA accelerated approval based specifically on improving mitochondrial energy supply to heart and muscle tissue.

Mitochondrial support

Its core, defining mechanism — binding directly to the inner mitochondrial membrane rather than working through a receptor.

Muscle function

Improved mitochondrial energy supply is linked to better muscle performance, especially under stress.

Reduced oxidative stress

Lowers cell-damaging byproducts specifically generated during mitochondrial energy production.